v3.26.1
FAIR VALUE MEASUREMENTS
 3 Months Ended
Jun. 30, 2026
Fair Value Disclosures [Abstract]  
FAIR VALUE MEASUREMENTS Fair Value Measurements
The Company measures certain financial assets and liabilities at fair value on a recurring basis. Refer to Note 4,
“Fair Value Measurements,” in the Company’s consolidated financial statements in Part IV of the 2026 Annual
Report for further information on the Company’s fair value accounting policies.
Assets and liabilities that are measured on a recurring basis at fair value in the condensed consolidated balance
sheets are as follows:
As of
Measured Using
June 30, 2026
Level 1
Level 2
Level 3
Assets:
Cash equivalents:
Money-market funds
$1,108,291
$1,108,291
$—
$—
Other current assets:
Designated Derivative Contracts asset
10,977
—
10,977
—
Other assets:
Non-qualified deferred compensation asset
27,483
27,483
—
—
Total assets measured at fair value
$1,146,751
$1,135,774
$10,977
$—
As of
Measured Using
June 30, 2026
Level 1
Level 2
Level 3
Liabilities:
Other accrued expenses:
Non-qualified deferred compensation liability
$(2,696)
$(2,696)
$—
$—
Other long-term liabilities:
Non-qualified deferred compensation liability
(36,626)
(36,626)
—
—
Total liabilities measured at fair value
$(39,322)
$(39,322)
$—
$—
As of
Measured Using
March 31, 2026
Level 1
Level 2
Level 3
Assets:
Cash equivalents:
Money-market funds
$1,462,683
$1,462,683
$—
$—
Other current assets:
Designated Derivative Contracts asset
7,316
—
7,316
—
Non-Designated Derivative Contracts asset
370
—
370
—
Other assets:
Non-qualified deferred compensation asset
22,845
22,845
—
—
Total assets measured at fair value
$1,493,214
$1,485,528
$7,686
$—
Liabilities:
Other accrued expenses:
Non-qualified deferred compensation liability
$(2,407)
$(2,407)
$—
$—
Other long-term liabilities:
Non-qualified deferred compensation liability
(29,291)
(29,291)
—
—
Total liabilities measured at fair value
$(31,698)
$(31,698)
$—
$—
The fair value of Designated Derivative Contracts and Non-Designated Derivative Contracts is determined by using
quoted market prices of the same or similar instruments, including spot and forward currency exchange rates,
adjusted for counterparty exposure and the Company’s own credit risk, if any. Refer to Note 7, “Derivative
Instruments,” for further information, including the definition of the terms Designated Derivative Contracts and Non-
Designated Derivative Contracts.